Other Events ·
Clearmind Medicine Inc. filed a patent application with the Hong Kong Patent Office for novel psychedelic compounds…
CMNDClearmind Medicine Inc.
Clearmind Medicine Inc. filed a patent application with the Hong Kong Patent Office for novel psychedelic compounds targeting Post-Traumatic Stress Disorder (PTSD) and other mental health disorders. This filing is part of its exclusive worldwide licensing agreement with Yissum Research Development Company of the Hebrew University of Jerusalem. Clearmind's intellectual property portfolio currently consists of nineteen patent families and 32 granted patents. Clearmind Medicine Inc. is a clinical-stage biotechnology company focused on the discovery and development of non-hallucinogenic, neuroplastogen-derived therapeutics for addiction and mental health disorders.